Great West Life Assurance CO Reata Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$79.22 - $105.37 $70,347 - $93,568	888 Added 69.43%	2,167 $222,000
Q1 2023 May 12, 2023	SELL	$30.85 - $93.17 $6,910 - $20,870	-224 Reduced 14.9%	1,279 $116,000
Q3 2022 Nov 01, 2022	BUY	$19.41 - $36.49 $29,173 - $54,844	1,503 New	1,503 $38,000
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $7,351 - $10,359	-78 Reduced 4.93%	1,503 $148,000
Q3 2020 Nov 17, 2020	BUY	$93.53 - $163.34 $147,870 - $258,240	1,581 New	1,581 $154,000
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $147,870 - $258,240	-1,581 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$126.3 - $176.56 $27,280 - $38,136	216 Added 15.82%	1,581 $244,000
Q4 2019 Feb 11, 2020	BUY	$74.57 - $217.92 $101,788 - $297,460	1,365 New	1,365 $279,000
Q3 2019 Oct 25, 2019	SELL	$71.26 - $95.75 $178,862 - $240,332	-2,510 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$77.72 - $94.35 $34,352 - $41,702	-442 Reduced 14.97%	2,510 $0
Q1 2019 May 08, 2019	BUY	$51.9 - $101.79 $47,799 - $93,748	921 Added 45.35%	2,952 $251,000
Q4 2018 Feb 12, 2019	BUY	$48.76 - $76.44 $55,147 - $86,453	1,131 Added 125.67%	2,031 $110,000
Q3 2017 Nov 09, 2017	BUY	$26.29 - $31.88 $23,661 - $28,692	900	900 $28,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.